On March 23, 2023 Capstan Therapeutics, Inc., a biotechnology company dedicated to advancing in vivo reprogramming of cells through targeted lipid nanoparticles, reported that Capstan management will participate in the following upcoming investor conferences (Press release, Capstan Therapeutics, MAR 23, 2023, View Source [SID1234629273]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of Genetic Medicines
Founding Chief Scientific Officer and Executive Vice President of R&D, Adrian Bot, M.D., Ph.D., will participate in a panel discussion titled "Novel LNPs Targeting Diverse Tissues" at 10:00 a.m. ET on Tuesday, March 28, 2023, at the virtual BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of Genetic Medicines.
2nd Annual Goldman Sachs Healthcare Disruption Conference
President and Chief Executive Officer, Laura Shawver, Ph.D., will attend the Goldman Sachs Healthcare Disruption Conference in New York City and will participate in a panel discussion titled "The Cell Therapy Re-Awakening" at 2:15 p.m. ET on Tuesday, April 4, 2023.
About Capstan (www.capstantx.com)